Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches
In silico study integrating multi-omics data analysis, computational modelling, text mining, and AI to suggest targeted COVID-19 therapies. Authors identified 54 potential targets using omic data analysis of SARS-CoV-2 infected cell lines and patient samples. Computational modelling highlighted interferons, renin-angiotensin system, and NLRP3 inflammasome as key antiviral and inflammatory pathways. Text mining retrieved 228 unique drugs/chemicals plus miRNAs targeting 46 of the identified nodes. Pharmacogenomic analysis revealed population differences in response for targets like AGTR1, IKBKE, CASP7, and EGFR.
Niarakis et al., 13 Feb 2024, peer-reviewed, 78 authors.
Contact:
anna.niarakis@inria.fr.
Abstract: TYPE Original Research
PUBLISHED 13 February 2024
DOI 10.3389/fimmu.2023.1282859
OPEN ACCESS
EDITED BY
Issam El Naqa,
University of Michigan, United States
REVIEWED BY
Stefano Casarin,
Houston Methodist Research Institute,
United States
Marcus Scotti,
Federal University of Paraı´ba, Brazil
*CORRESPONDENCE
Anna Niarakis
anna.niarakis@inria.fr
†
PRESENT ADDRESS
Anna Niarakis,
Centre de Biologie Integrative, Pole de
Biologie Computationnelle des Systèmes,
Univ. Toulouse III - Paul Sabatier, France
SPECIALTY SECTION
RECEIVED 24 August 2023
ACCEPTED 22 December 2023
PUBLISHED 13 February 2024
CITATION
Niarakis A, Ostaszewski M, Mazein A,
Kuperstein I, Kutmon M, Gillespie ME,
Funahashi A, Acencio ML, Hemedan A,
Aichem M, Klein K, Czauderna T, Burtscher F,
Yamada TG, Hiki Y, Hiroi NF, Hu F, Pham N,
Ehrhart F, Willighagen EL, Valdeolivas A,
Dugourd A, Messina F, Esteban-Medina M,
Peña-Chilet M, Rian K, Soliman S,
Aghamiri SS, Puniya BL, Naldi A, Helikar T,
Singh V, Fernández MF, Bermudez V,
Tsirvouli E, Montagud A, Noël V,
Ponce-de-Leon M, Maier D, Bauch A,
Gyori BM, Bachman JA, Luna A, Piñero J,
Furlong LI, Balaur I, Rougny A, Jarosz Y,
Overall RW, Phair R, Perfetto L, Matthews L,
Rex DAB, Orlic-Milacic M, Gomez LCM,
De Meulder B, Ravel JM, Jassal B,
Satagopam V, Wu G, Golebiewski M,
Gawron P, Calzone L, Beckmann JS,
Evelo CT, D’Eustachio P, Schreiber F,
Saez-Rodriguez J, Dopazo J, Kuiper M,
Valencia A, Wolkenhauer O, Kitano H,
Barillot E, Auffray C, Balling R, Schneider R
and the COVID-19 Disease Map Community
(2024) Drug-target identification in COVID-19
disease mechanisms using computational
systems biology approaches.
Front. Immunol. 14:1282859.
doi: 10.3389/fimmu.2023.1282859
Frontiers in Immunology
Drug-target identification in
COVID-19 disease mechanisms
using computational systems
biology approaches
Anna Niarakis 1,2*†, Marek Ostaszewski 3, Alexander Mazein 3,
Inna Kuperstein 4,5,6, Martina Kutmon 7, Marc E. Gillespie 8,9,
Akira Funahashi 10, Marcio Luis Acencio 3, Ahmed Hemedan 3,
Michael Aichem 11, Karsten Klein 11, Tobias Czauderna 12,
Felicia Burtscher 3, Takahiro G. Yamada 10, Yusuke Hiki 13,
Noriko F. Hiroi 14,15, Finterly Hu 7,16, Nhung Pham 7,16,
Friederike Ehrhart 16, Egon L. Willighagen 16,
Alberto Valdeolivas 17, Aurelien Dugourd 17, Francesco Messina 18,
Marina Esteban-Medina 19,20, Maria Peña-Chilet 19,20,21,
Kinza Rian 19, Sylvain Soliman 2, Sara Sadat Aghamiri 22,
Bhanwar Lal Puniya 22, Aurélien Naldi 2, Tomáš Helikar 22,
Vidisha Singh 1, Marco Fariñas Fernández 23, Viviam Bermudez 23,
Eirini Tsirvouli 23, Arnau Montagud 24, Vincent Noël 4,5,6,
Miguel Ponce-de-Leon 24, Dieter Maier 25, Angela Bauch 25,
Benjamin M. Gyori 26, John A. Bachman 26, Augustin Luna 27,28,
Janet Piñero 29,30, Laura I. Furlong 29,30, Irina Balaur 3,
Adrien Rougny 31,32, Yohan Jarosz 3, Rupert W. Overall 33,
Robert Phair 34, Livia Perfetto 35, Lisa Matthews 36,
Devasahayam Arokia Balaya Rex 37, Marija Orlic-Milacic 8,
Luis Cristobal Monraz Gomez 4,5,6, Bertrand De Meulder 38,
Jean Marie Ravel 4,5,6, Bijay Jassal 8, Venkata Satagopam 3,39,
Guanming Wu 40, Martin Golebiewski 41, Piotr Gawron 3,
Laurence Calzone 4,5,6, Jacques S. Beckmann 42, Chris T. Evelo 16,
Peter D’Eustachio 36, Falk Schreiber 11,43, Julio Saez-Rodriguez 17,
Joaquin Dopazo 19,20,21,44, Martin Kuiper 23, Alfonso Valencia 24,45,
Olaf Wolkenhauer 46,47, Hiroaki Kitano 48, Emmanuel Barillot 4,5,6,
Charles Auffray 38, Rudi Balling 49, Reinhard Schneider 3
and the COVID-19..
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers.
Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit